An IHC stained image of tumor.
An immunohistochemically stained image showcasing tumor tissue.
The image presents tumor tissue visualized through IHC staining.
A histological section stained using IHC, highlighting tumor structures.
An IHC-stained tissue sample displaying tumor morphology.
Tumor cells are observed in this IHC-stained histopathology image.
A high-resolution IHC-stained section highlighting tumor tissue.
This image captures tumor structures stained using immunohistochemical techniques.
An IHC-prepared sample showing tumor tissue distribution.
The image provides an IHC-based visualization of tumor architecture.
A microscopic view of tumor regions stained using IHC markers.

An IHC image of Tumor stained using the CD20 biomarker.
The image presents tumor tissue stained with the CD20 biomarker using IHC techniques.
CD20-stained tumor structures are visualized in this IHC micrograph.
An IHC-stained section highlights tumor tissue marked by CD20.
CD20-positive staining is observed in tumor tissue in this IHC-stained sample.
The immunohistochemistry image features tumor tissue with CD20 expression.
This IHC-stained tissue section reveals tumor structures marked with CD20.
An IHC-stained micrograph of tumor tissue exhibiting CD20 positivity.
The presence of CD20-expressing cells is confirmed in tumor tissue through IHC staining.
The image presents tumor structures stained with the CD20 biomarker in an IHC tissue section.
A microscopic view of tumor tissue showing CD20-positive staining through IHC techniques.

Tumor tissue with faint staining is observed, likely indicating vascular or endothelial involvement.
The image shows tumor tissue with faint staining, suggesting possible vascular or endothelial presence.
Faint staining in tumor tissue indicates minimal endothelial or vascular involvement.
Tumor structures exhibit light staining, likely marking endothelial or vascular activity.
A subtle staining pattern in tumor tissue suggests mild vascular involvement.
Faintly stained regions in tumor tissue may indicate endothelial cell distribution.
The presence of faint staining in tumor structures suggests limited microvascular activity.
A weak staining pattern in tumor tissue marks potential vascular component involvement.
Tumor tissue presents faint staining, likely representing endothelial or vascular cells.
Minimal staining is observed in tumor sections, suggesting low endothelial or vascular presence.
The image highlights tumor structures with faint staining, marking potential vascular contribution.

CD34-positive cells in tumor tissue exhibit faint staining, likely representing endothelial cells or microvascular structures.
CD34-expressing cells in tumor tissue show faint staining, indicating endothelial or microvascular involvement.
The image presents tumor tissue with weak CD34 staining, suggesting the presence of endothelial cells.
Faint CD34 staining in tumor tissue highlights microvascular components.
Tumor sections exhibit mild CD34 staining, likely marking endothelial cell populations.
CD34-positive staining is faint in tumor tissue, suggesting subtle vascular structures.
Weak CD34 staining in tumor-associated cells indicates minimal endothelial cell activity.
The presence of faintly stained CD34-positive cells suggests microvascular formation.
CD34 expression in tumor tissue is observed as faint staining, marking endothelial components.
Tumor sections show low-intensity CD34 staining, highlighting microvascular activity.
CD34-positive cells in tumor tissue display mild staining, confirming endothelial involvement.

CD34 staining highlights endothelial cells in tumor tissue with faint positivity, suggesting the presence of vascular structures potentially supporting the tumor microenvironment.
CD34 staining in tumor tissue reveals faint positivity, marking endothelial cell presence.
The image highlights endothelial cells in tumor tissue with mild CD34 staining.
A weak CD34 staining pattern in tumor tissue suggests limited vascular structure formation.
Faintly stained CD34-positive cells in tumor tissue indicate endothelial involvement.
CD34 expression in tumor-associated endothelial cells appears as faint staining.
Tumor sections exhibit weak CD34 staining, suggesting vascular structures supporting the microenvironment.
A mild CD34 staining pattern in tumor tissue marks potential microvascular development.
Endothelial cells in tumor structures show faint CD34 staining, marking vascularization.
The presence of CD34-positive endothelial cells in tumor tissue suggests limited angiogenesis.
CD34 staining in tumor tissue appears faint, indicating subtle endothelial contributions to the tumor microenvironment.

The Immunohistochemistry image shows a pattern of a partially negative and partially positive tumor stained with CD34, indicating the presence of hematopoietic cells that express the CD34 marker.
The IHC image presents a tumor with a mixed pattern of CD34 staining, showing both positive and negative regions.
CD34 staining in tumor tissue appears partially positive and partially negative, suggesting heterogeneous expression.
The image highlights areas of both CD34 positivity and negativity in tumor tissue, marking hematopoietic cell presence.
A distinct pattern of partial CD34 positivity in the tumor suggests selective expression in hematopoietic cells.
CD34 immunostaining in the tumor reveals a mixed pattern, confirming the presence of hematopoietic cells.
The image shows tumor tissue with focal CD34 positivity, indicating the expression of this marker in specific regions.
A partially positive and partially negative staining pattern for CD34 is observed, suggesting heterogeneous hematopoietic activity.
CD34 staining highlights hematopoietic cell distribution in tumor tissue, with areas of variable positivity.
The presence of both CD34-positive and CD34-negative regions in the tumor suggests selective marker expression.
The image captures tumor heterogeneity, with partial CD34 positivity marking hematopoietic involvement.

The Immunohistochemistry image of the class tumor stained with the biomarker CD34 shows a weak to moderate expression of the marker in the tumor cells, with some cells showing strong positivity.
The IHC image reveals weak to moderate CD34 staining in tumor cells, with focal areas of strong positivity.
CD34 expression in tumor cells appears variable, ranging from weak to moderate, with some strongly stained regions.
The image highlights tumor tissue with heterogeneous CD34 staining, showing areas of both low and high expression.
A mixed staining pattern for CD34 is observed, with some tumor cells exhibiting strong positivity.
CD34 immunostaining in the tumor tissue shows variable expression, suggesting differential marker distribution.
Tumor cells exhibit a range of CD34 staining intensities, from weak to strong positivity.
The image presents tumor cells with moderate CD34 staining, with some focal areas of higher intensity.
CD34 staining in tumor tissue is heterogeneous, with a combination of weak, moderate, and strong expression patterns.
The tumor exhibits variable CD34 expression, marking differences in endothelial or progenitor cell distribution.
A weak to moderate CD34 staining pattern in tumor cells suggests selective expression of the marker in certain areas.


The image shows a positive immunohistochemistry stain for CD34 in a tumor, indicating the presence of endothelial cells.
CD34-positive staining in tumor tissue confirms the presence of endothelial cells.
The image highlights endothelial cells in tumor tissue through positive CD34 immunostaining.
CD34 expression is observed in the tumor, marking endothelial cell presence.
A positive CD34 immunostaining pattern in tumor tissue confirms endothelial involvement.
Endothelial cells are identified in the tumor microenvironment through CD34-positive staining.
CD34 staining in tumor tissue appears positive, indicating active endothelial cell presence.
The image presents a tumor with CD34-positive endothelial cell staining, confirming vascular involvement.
CD34-positive staining in tumor structures suggests active endothelial participation.
Endothelial cells in tumor tissue show positive CD34 staining, marking their contribution to vascularization.
A positive CD34 immunostaining signal in tumor tissue confirms the presence of endothelial cells.


The image shows a positive immunohistochemistry staining for CD34 in a tumor, indicating the presence of endothelial cells.
The IHC image confirms CD34-positive endothelial cells in tumor tissue.
CD34 staining highlights endothelial cells in the tumor, supporting vascular involvement.
A strong CD34-positive immunostaining pattern is observed in tumor tissue, marking endothelial cell presence.
Endothelial cell distribution in the tumor is confirmed through positive CD34 staining.
CD34-positive staining in tumor tissue marks endothelial involvement in tumor vascularization.
The presence of CD34-positive endothelial cells suggests active angiogenesis in the tumor.
CD34 staining in the tumor highlights endothelial cells, marking vascular structures.
The image presents tumor tissue with distinct CD34-positive endothelial cell staining.
CD34 immunostaining confirms vascular endothelial presence in the tumor microenvironment.
A positive CD34 staining reaction in tumor tissue highlights the involvement of endothelial cells in tumor growth.
